Medistim ASA (FRA:MD1)
€ 12.15 -0.25 (-2.02%) Market Cap: 226.29 Mil Enterprise Value: 216.00 Mil PE Ratio: 23.78 PB Ratio: 5.97 GF Score: 90/100

Q1 2022 Medistim ASA Earnings Call Transcript

Apr 28, 2022 / NTS GMT
Release Date Price: €26.7 (-0.74%)
Kari Krogstad
Medistim ASA - President & CEO

Good morning, everyone, and welcome to Medistim (technical difficulty) 2022 presentation. My name is Kari Krogstad. And together with the colleague, CFO Thomas Jakobsen, we will take you through the results from this quarter.

And we are going to follow our agenda starting with the highlights, and then Thomas will take us through the financial statements. And then we will go through some further comments on the business segments and also some comments with regarding implementing our strategy. So let's get started on the highlights. So I'm very pleased to being able to present that again we are presenting an all-time high sales quarter. So this is actually the fifth quarter in a row where Medistim is delivering a sales number above NOK100 million. And as we can see, reaching NOK116.1 million compared to the NOK102.6 million last year, a growth of 13.2%.

As we can see, we have a little bit of favorable currency here, but not much. And the growth is coming from where we want it to come from. As we can see, the imaging portfolio, so the combined

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot